The institutional investor owned 46,921 shares of the biotechnology company’s stock after purchasing an additional 15,313 shares during the period. Strategic Investment Advisors MI’s holdings in Exelixis were worth $2,012,000 at the end of the most recent reporting period. Get Exelixis alerts:Exelixis Price PerformanceShares of Exelixis stock opened at $55.27 on Thursday. UBS Group reiterated a “buy” rating on shares of Exelixis in a research report on Thursday, July 2nd. Following the sale, the executive vice president owned 357,638 shares of the company’s stock, valued at $17,813,948.78.